Unbound MEDLINE

Antiphosphatidylethanolamine antibodies and the antiphospholipid syndrome. Lupus [Lupus] Journal article

 
TitleAntiphosphatidylethanolamine antibodies and the antiphospholipid syndrome.
Author(s)Sanmarco M, Boffa MC 
InstitutionLaboratoire d'Immunologie, Hôpital de La Conception. Marseille, France msanmarco@ap-hm.fr.
SourceLupus 2009; 18(10):920-3.
AbstractThe antiphospholipid antibodies included as laboratory criteria of the antiphospholipid syndrome (APS) are antibodies reacting with anionic phospholipids - anticardiolipin antibodies and lupus anticoagulant - and with beta(2)-glycoprotein I. However, antibodies reacting with phosphatidylethanolamine (aPE), a zwitterionic phospholipid, have also been described to be associated with the main features of APS. The objectives of this review are to describe the characteristics of aPE and to bring attention to recent evidence that aPE are correlated with the main clinical features of APS, notably, in the absence of the laboratory criteria of this syndrome.
Languageeng
Pub Type(s)Journal Article
PubMed ID19671793
  
Advertise on this site.